PIROUETTE PHARMA INC. filed a Form D with the Securities and Exchange Commission on 2026-03-18.
PIROUETTE PHARMA INC. filed a Form D notice of an exempt securities offering with the SEC on March 18, 2026. The filing reports $1.08M sold. Its industry group is Pharmaceuticals. It names CONOR CULLINANE (Executive Officer, Director, Promoter), JOSEPH NEMMERS (Director), PARINAZ MOTAMEDY (Director) (SEC Form D, March 18, 2026).
Sell to companies like PIROUETTE PHARMA INC? Enter your website and see 10 with a filed reason to buy from you this month. Free.
Opens in a new tab. No signup.
New Form D on file · 2026-03-18 · the record
Pitching, partnering or investing alongside them? See who really runs and owns PIROUETTE PHARMA INC.
Free to see. No signup.
More on the people and the money behind PIROUETTE PHARMA INC., from the filings we hold.
Pharmaceuticals raises filed within 90 days of this one, largest first.
Get an email when PIROUETTE PHARMA INC. files again: a new raise, a leadership change, a layoff or an IPO filing. One email first to confirm; nothing else until you click it. At most one a day, one click to stop. Free for up to 3 companies.
We'll show it in your MentionFox inbox when PIROUETTE PHARMA INC. raises, hires or launches. No email unless you switch it on.
Watch PIROUETTE PHARMA INC. →Get the full cited report on PIROUETTE PHARMA INC.
What the filing shows about PIROUETTE PHARMA INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on PIROUETTE PHARMA INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
Saved here on this device in the meantime, so nothing is lost either way.
Full funding history for PIROUETTE PHARMA INC. →
This is the company's own disclosure. A payment disclosed on a Form D is a disclosed use of proceeds, not a finding of wrongdoing.
Each marker is one filing. The larger marker is the filing this page is about.
Trailing twelve months. 157 filings in Pharmaceuticals, totalled by week. The dot is this raise, $1.08M, on the same scale — one filing against the whole group's total, so it sits low by construction.
Conor Cullinane is named as Executive Officer and Director and Promoter on the Form D that PIROUETTE PHARMA INC. filed with the SEC on 18 March 2026, one of 5 people that filing names.
Joseph Nemmers is named as Director on the Form D that PIROUETTE PHARMA INC. filed with the SEC on 18 March 2026, one of 5 people that filing names.
Parinaz Motamedy is named as Director on the Form D that PIROUETTE PHARMA INC. filed with the SEC on 18 March 2026, one of 5 people that filing names.
Matthew Kane is named as Executive Officer and Director and Promoter on the Form D that PIROUETTE PHARMA INC. filed with the SEC on 18 March 2026, one of 5 people that filing names.
Elijah Kapas is named as Executive Officer and Promoter on the Form D that PIROUETTE PHARMA INC. filed with the SEC on 18 March 2026, one of 5 people that filing names.
5 people named on the filing — 3 holding an executive role and 2 as directors only.
Named as of the 2026-03-18 filing. Titles and locations are exactly as the filing states — not independently confirmed elsewhere.
No investor is drawn from a Form D — the form states how many invested and never who.
What the filing shows about PIROUETTE PHARMA INC.
Only in the Full Report: Who Runs It, And How To Reach Them · Warning Bells · Who Pays Them, And Who They Are Up Against.
Example from a real report (our sample on Target): “In March 2026, Target announced a planned incremental $1 billion operating investment” Source: Target Corporation (press release)
A Full Report on PIROUETTE PHARMA INC.: verified, sourced, every claim cited, ready in a few minutes. See pricing.
What the Full Report on PIROUETTE PHARMA INC. covers
Plus the sections for what you are deciding, which you pick after ordering.
A real finished report, first screen. Opens in a new tab.
Not ready to order yet? Keep this snapshot.
Sends this preview to you once; we won't add you to any list
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist PIROUETTE PHARMA INC.You get an alert in MentionFox the next time this company shows up.
If you're behind PIROUETTE PHARMA INC.: the weeks after a raise are watched the same way — by other investors sizing you up, and by founders checking who just got funded. FoxPlug turns your commits, deploys, and releases into that story automatically. GetFoxChat puts a guide on your own site so the people this filing just sent you don't leave after one page.
Sourced from the filing index on sec.gov.
Each opens in a new tab, filled in for PIROUETTE PHARMA INC.. With no account yet, you sign up free and land on the result.
https://mentionfox.com/funding/pirouette-pharma-inc-form-d-26000001